training of trainer on · cvd risk among screened patients ( 2017 may -2018 dec ) from 149...
TRANSCRIPT
Training of Trainer on
Prevention and Treatment of Major NCDs in the Community
12/1/2019 Monywa 2-4 December 2019
12/1/2019
Global Burden of NCD
12/1/2019
• Non-communicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally.
• Each year, 15 million people die from a NCD between the ages of 30 and 69 years; over 85% of these "premature" deaths occur in low- and middle-income countries.
• Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.0 million), respiratory diseases (3.9million), and diabetes (1.6 million).
• These 4 groups of diseases account for over 80% of all premature NCD deaths.
Source :WHO
Source: WHO Global Health Estimates 2014 (Year: 2012), Deaths by age group
Communicable, maternal, perinatal and nutritional conditions
NCDs Injuries
41 million of the 57 million global deaths in 2016 were due to NCDs
-
5,000,000.00
10,000,000.00
15,000,000.00
20,000,000.00
25,000,000.00
0 to 29 30 to 69 70 and beyond
12/1/2019
Source: WHO Global Health Estimates 2014 (Year: 2012), Deaths by age group
Communicable, maternal, perinatal and nutritional conditions
NCDs Injuries
15 million people died from NCDs in 2016 between ages 30 and 70
-
5,000,000.00
10,000,000.00
15,000,000.00
20,000,000.00
25,000,000.00
0 to 29 30 to 69 70 and beyond
12/1/2019
More than 2 million new cases SEAR Region
Estimated number of Cancer New Case Both Sex , All Age
Data Source : Globocan 2018
12/1/2019
New cancer cases in 2018 in SEAR
Data Source : Globocan 2018
12/1/2019
Myanmar 2018
12/1/2019
Myanmar 2018
12/1/2019
12/1/2019
Myanmar Cancer Number at a glance
12/1/2019
Myanmar and NCD Overview
• Population- 51,486,253 (Census 2014)
• Epidemiological transition taking place in the country the same with Regional and Global trend
• 94% adults live with at least 1 risk factor of NCDs (STEPS 2014)
• 68% deaths due to NCDs (WHO-2017)
12/1/2019
Myanmar is unlikely to meet the target for reducing premature mortality from NCDs unless urgent prioritized actions implemented
• Cardiovascular diseases (heart attack and stroke) are the leading causes of mortality responsible for one out of every four deaths
• Most premature deaths from cardiovascular diseases can be prevented
12/1/2019
Distribution of NCD Patients in Hospital Admission -Myanmar 2014-2016
Source: Hospital Statistics Report (2014-2016) 12/1/2019
Morbidity due to NCDs in Hospital Admitted Patients 2014-2016
Source: Hospital Statistics Report (2014-2016)
12/1/2019
0
1000
2000
3000
4000
5000
6000
7000
8000
Total Stroke Patient Cerebral Infarct Cerebral Hemorrhage
The Stroke Patient admitted to Yangon General Hospital in Year 2016
7333
4968
2365 (67.7%)
(32.3%)
12/1/2019
0
1000
2000
3000
4000
5000
6000
7000
Total Stroke Patient Cerebral Infarct Cerebral Hemorrhage
The Stroke Patient admitted to Yangon General Hospital in Year 2017
4597
1914
6511
(70.6%)
(29.4%)
12/1/2019
Cause of death distribution - Cause Specific Mortality Fraction (CSMF)
All ages in 42 townships (Jan-June 2018)
21%
10
%
9%
6%
6%
3%
3%
2%
2%
2%
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
5%
10%
15%
20%
25%
Stro
keCh
roni
c Re
spira
tory
Isch
emic
Hea
rt D
iseas
eCi
rrho
sisDi
abet
esO
ther
Non
-com
mun
icab
le D
iseas
esPn
eum
onia TB
Chro
nic
Rena
l Fai
lure
Leuk
emia
/Lym
phom
asAI
DSEs
opha
geal
Can
cer
Falls
Lung
Can
cer
Road
Tra
ffic
Pros
tate
Can
cer
Cerv
ical
Can
cer
Brea
st C
ance
rSt
omac
h Ca
ncer
Diar
rhea
/Dys
ente
ryDr
owni
ngO
ther
Infe
ctio
us D
iseas
esO
ther
Can
cers
Oth
er In
jurie
sCh
ildho
od C
ardi
ovas
cula
r Dise
ases
Mat
erna
lFi
res
Neo
nata
l Men
ingi
tis/S
epsis
Bite
of V
enom
ous A
nim
alSu
icid
ePo
isoni
ngs
Colo
rect
al C
ance
rM
alar
iaHo
mic
ide
Cong
enita
l mal
form
atio
nDi
gest
ive
Dise
ases
Oth
er C
ardi
ovas
cula
r Dise
ases
Birt
h as
phyx
iaCh
ildho
od C
ance
rPr
eter
m D
eliv
ery
Men
ingi
tisN
eona
tal P
neum
onia
Oth
er D
efin
ed C
ause
s of C
hild
Dea
ths
Ence
phal
itis
Mea
sles
Hem
orrh
agic
feve
r
Source : Myanmar Verbal autopsy in 42 townships, Jan to June 2018 12/1/2019
12/1/2019
What are NCDs Risk Factors?
Underlying Determinants Globalization Urbanization
Population Ageing Social
Determinants
Behavioral Risk
Factors: Unhealthy diet
Tobacco smoking Harmful use of
alcohol Physical Inactivity
Physiological / Metabolic Risk
Factors Raised Blood Pressure Raised Blood Glucose
Raised Blood Cholesterol
Overweight/Obesity Abnormal lung function
Diseases Cardiovascular
diseases Cancers Diabetes
Chronic Obstructive Respiratory Diseases
Premature death
Source: Adapted from Preventing Chronic Disease: a Vital Investment. Geneva, World Health Organization, 2005.
12/1/2019
Current tobacco use among adult men (in %)
62
16
2
26
31
1
26
30
4
27
44
70
67
45
27
47
29
19
35
11
80
71
67
58
48
47
46
42
36
34
0 10 20 30 40 50 60 70 80 90
Myanmar
Timor-Leste
Indonesia
Bangladesh
Nepal
Thailand
Sri Lanka
India
Maldives
Bhutan
Total
Smoking
Smokeless
Source :WHO STEP survey 2014 12/1/2019
Current tobacco use among adult women (in %)
24
27
28
5
13
11
5
5
2
1
8
10
2
10
2
3
3
3
3
29
29
29
14
14
14
8
5
5
4
0 5 10 15 20 25 30 35
Myanmar
Timor-Leste
Bangladesh
Nepal
India
Bhutan
Thailand
Sri Lanka
Indonesia
Maldives
Total
Smoking
Smokeless
12/1/2019
Current tobacco use among youth (boys, in %)
6.7
9.2
15.2
19
21.8
24.6
26.3
36.2
39
65.5
3.2
4
10.4
11.2
20.7
11.4
21.1
35.3
26.3
61.4
4.2
5.9
9.2
11.1
4.1
19.7
11
3
25
7.7
0 10 20 30 40 50 60 70
Sri Lanka
Bangladesh
Maldives
India
Thailand
Nepal
Myanmar
Indonesia
Bhutan
Timor-Leste
Smokeless
Smoking
Total
Source GYTS 2016
12/1/2019
Current tobacco use among youth (girls, in %)
0.7
2.8
3.7
4.3
6.7
8.1
8.3
16.4
23.2
23.9
0.2
1.1
2.4
3.4
5
7.1
3.7
6.5
8.6
15.4
0.5
2
1.5
1.1
2.9
1.3
6
12.9
18.9
9.3
0 5 10 15 20 25 30
Sri Lanka
Bangladesh
Myanmar
Indonesia
Maldives
Thailand
India
Nepal
Bhutan
Timor-Leste
Smokeless
Smoking
Total
Source GYTS 2016
12/1/2019
Findings of STEP survey, 2014 Description Male Female Both sexes
Percentage of current smoker 43.8 % 8.4% 26.1%
Percentage of current smokeless tobacco user
62.2 % 24.1% 43.2 %
Percentage of with raised fasting blood glucose or raised 2-h blood or currently on medications for raised blood glucose
9.1% 11.8% 10.5 %
Percentage of overweight in adult (BMI >25 kg/m2 )
14.1% 30.8% 22.4 %
Percentage of adult Obesity (BMI >30kg/m2 )
2.6% 8.4% 5.5 %
Percentage of adults with raised blood pressure (SBP ≥140 and/or DBP ≥90 mmHg)
24.7% 28% 26.4 %
Percentage of Adult with high blood cholesterol level
30.9% 42.5% 36.7 %
Percent age of current drinker 38.1% 1.5% 19.8 %
12/1/2019
12/1/2019
The WHO Global NCD Action Plan 2013-2020 – six objectives
Commits governments to develop national responses: Target 3.4: By 2030, reduce by one third
premature mortality from NCDs Target 3.5: Strengthen responses to
reduce the harmful use of alcohol Target 3.8: Achieve universal health
coverage Target 3.a: Strengthen the
implementation of the WHO Framework Convention on Tobacco Control
Target 3.b: Support research and development of vaccines and medicines for NCDs that primarily affect developing countries
Target 3.b: Provide access to affordable essential medicines and vaccines for NCDs
Historic crossroads: NCDs included in the 2030 Agenda for Sustainable Development
12/1/2019
SDG targets for 2030 are aligned with the NCD targets for 2025 12/1/2019
12/1/2019
DOPH –NCD Unit
DM CVD
Cancer CRD
Snake Bite
Mental Health
Epilepsy
RTA Deafness
Rehab
12/1/2019
Are NCDs Preventable and How?
• Most Premature Deaths and Suffering from NCD are preventable
• NCD Best Buys
12/1/2019
NCD Prevention and Control
Prevention • To focus on reducing the risk
factors associated with Major NCDs – Promote Physical Activities – Tobacco Control – Alcohol Control – Unhealthy Diet
• Health Promotion • Low-cost solutions exist for
governments and other stakeholders
Control • PEN approach for major
NCD • Preventive Cardiology for
early detection and treatment
• It is also secondary Prevention to reduce complication
12/1/2019
Population-wide
interventions Multi-sectoral
Individualised interventions Health Sector
"Best buy" Interventions Risk factor / disease
- Raise taxes on tobacco - Protect people from tobacco smoke - Warn about the dangers of tobacco - Enforce bans on tobacco advertising
Tobacco use
- Raise taxes on alcohol - Restrict access to retailed alcohol - Enforce bans on alcohol advertising
Harmful use of alcohol
- Reduce salt intake in food - Replace trans fat with polyunsaturated fat - Promote public awareness about diet and physical
activity
Unhealthy diet and physical inactivity
- Provide counselling and multi-drug therapy for people with medium-high risk of developing heart attacks and strokes
- Treat heart attacks with aspirin
Cardiovascular disease and diabetes
- Hepatitis B immunization beginning at birth to prevent liver cancer
- Screening and treatment of pre-cancerous lesions to prevent cervical cancer
Cancer
NCD
Bes
t Buy
s
12/1/2019
DOPH - NCD Screening and Treatment
• Secondary Prevention of Major NCD at PHC Level • Based on WHO PEN approach • Service include Screening and Treatment of DM and
HT , Screening of Oral , Breast and Cervical Cancers • 10 yr CVD risk assessment is conducted • Covered 232 townships (from 2017 May up to date ) • In April 2019 - Ministry of Health and Sports initiate
to go a big way on preventive cardiology
12/1/2019
Community Health Clinics Cum Diabetes , Hypertension Screening , Diagnosis
and Treatment Clinics
20 Townships
CHC
12/1/2019
PEN Approach Vs CHC Approach Preparation /
implementation PEN CHC
Training Conducted Not able to Conduct
IEC Material Provided Not Provided
Supplies & Equipment Provided From PEN Supplies
Interventions • Screening and Treatment of DM, HT
• CVD Risk assessment • Cancer Screening • Chronic Respiratory Disease
Treatment • Health Promotion
• Screening and Treatment of DM, HT
• CVD Risk assessment • Elderly Care • Health Promotion
Focal Unit NCD Basic Health
Implementation Site RHC and SRHC RHC
Township Covered Trained 232 Townships All Township
12/1/2019
Training and Implementing of Diabetes and Hypertension Clinics in PEN Approach
(2017 May – 2019 February) 18
7 7 9
10
10
7
11
9
10
17
45
11
20 21
12
8
232
27
21
14
19
3
14
98
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Perc
enta
ge
State/Region 12/1/2019
Total Screened Patient by State/Region ( 2017 May -2018 Dec ) from 149 Townships
6954
1673
2 6126
5
7150
1
7342
0
5722
7
9828
0
6407
9
7109
8
3471
1
1210
23
1535
8
6916
48
0
100000
200000
300000
400000
500000
600000
700000
Num
ber o
f Scr
eene
d pe
ople
State/Region
12/1/2019
Diabetes among screened patients ( 2017 May -2018 Dec ) from 149 Townships
Diabetes, 104245, 15%
Non Diabetes, 587403, 85%
12/1/2019
Hypertension among screened patients ( 2017 May -2018 Dec ) from 149 Townships
Hypertension, 231398, 33%
Without Hypertension, 460250, 67%
12/1/2019
CVD Risk among screened patients ( 2017 May -2018 Dec ) from 149 Townships
CVD Risk (<10%), 752991, 78%
115950, 12%
61343, 6%
33824, 4%
CVD Risk (>=10%), 211117, 22%
CVD Risk (<10%)
CVD Risk 10 - <20%
CVD Risk 20 - <30%
CVD Risk >=30%
12/1/2019
Assessment of Cardio Vascular Risk in NCD Clinic
12/1/2019
Weakness of NCD Clinics
Coverage • Not planned Target
Population • Most Clinic are Facility
Based • Community outreach are
still weak in most Townships • Lack of support for
Outreach Services • Awareness about NCD
Clinics is low
Quality of Care • High Lost to follow up • Team-based approach is a
challenge • Weak coordination among
Hospital Doctors and BHS • Some staff need training • Screening of Cancer is weak
12/1/2019
Weakness of NCD Clinics -contd
Supplies • Replenishment of medicines
is not possible • Weak supply Chain • All items of NCD medicines
are not procured • Not product segmentation
(Central & Regional Supplies)
M and E • Clinical mentoring and
supportive supervision is weak
• Health outcome monitoring system
• Community outreach are still weak in most Townships
• Limited support for M&E at all level
12/1/2019
Providers’ reasons for not readiness at NCD Clinics (n=47)
Reasons given by BHS (multiple responses)
No. of providers by type of facility Total
No. (%) MCH n = 6
RHC n = 21
Sub RHC n = 20
Facility had not enough medicines for NCDs 6 19 15 40 (85.1%)
Facility had not enough equipment 6 11 8 25 (53.2%)
Facility had not full staff 2 3 4 9 (19.2%)
Health staff were already overload 0 2 1 3 (6.4%)
Facility had no trained staff for NCDs 0 0 1 1 (2.1%)
Other 0 5 7 12 (25.5%)
Study on Preparedness and responsiveness of NCD service delivery: PEN clinics, Myanmar( 2019 April –May ) 12/1/2019
Reported NCD medicines used at PEN clinics by type of facility (n = 131)
Type of medicines Type of facility
MCH RHC Sub RHC Special clinic
Total No. (%)
Amlodipine 5 mg 13 52 57 3 125 (95.4%)
Atenolol50 mg 4 8 10 1 23 (17.6%)
Enalapril5 mg 0 8 5 0 13 (9.9%)
Metformin 500 mg 13 49 47 2 111 (84.7%)
Gliclazide80 mg 10 31 30 2 73 (55.7%)
Aspirin 75 mg 2 8 12 1 23 (17.6%)
Atorvastatin10 mg 2 3 4 0 9 (6.9%)
Study on Preparedness and responsiveness of NCD service delivery: PEN clinics, Myanmar( 2019 April –May )
12/1/2019
Providers’ reasons for not readiness at NCD Clinics (n=47)
Types of refilling (Multiple responses)
Essential medicines Equipment
No. % No. %
Received from higher level 64 48.9 64 48.9
Bought by using different funding sources 27 20.6 18 13.7
Bought by staff with own expense 28 21.4 25 19.1
Bought by patients 4 3.1 2 1.5
Shared among facilities 0 1 0.8
Don’t know 0 1 0.8
Study on Preparedness and responsiveness of NCD service delivery: PEN clinics, Myanmar( 2019 April –May ) 12/1/2019
NCD Clinic in Preventive Cardiology Approach
12/1/2019
1st Preventive Cardiology meeting, Mingalarthiri Hotel, Nay Pyi Taw(15-5-2019)
12/1/2019
12/1/2019